14:46 EDT 23rd March 2018 | BioPortfolio

Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women’s health. We are engaged in drug development activities and in the promotion of products for others. The focus of our business development efforts is the acquisition of licenses to products that are relevant to our therapeutic areas of focus. We also intend to license out certain commercial rights of internally developed products to licensees in territories where such out-licensing would enable us to ensure development, registration and launch of our product candidates. Our goal is to become a growth-oriented specialty biopharmaceutical company by pursuing successful development and commercialization of our product portfolio, achieving successful commercial presence and growth, while consistently delivering value to our shareholders, employees and the medical providers and patients who will benefit from our products. For more information, visit

News Articles [41 Associated News Articles listed on BioPortfolio]

Comparing AEterna Zentaris

AEterna Zentaris and AC Immune are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analys...

Aeterna Zentaris Forges $24M Tie-Up With Strongbridge

Strongbridge will fund 70% of the costs of a worldwide pediatric development program to be run by Aeterna Zentaris with customary oversight from a joint steering committee.

Post-review, Aeterna Zentaris strikes commercialization deal

After a complicated year including a strategic review, Quebecois company Aeterna Zentaris inks a small deal to help it move forward. 

Aeterna Zentaris Announces FDA Approval of Macrilen (macimorelin) for Diagnosis of Adult Growth Hormone Deficiency

CHARLESTON, S.C. December 20, 2017 -- Aeterna Zentaris Inc. (NASDAQ and TSX: AEZS), a specialty biopharmaceutical company engaged in developing and commercializing pharmaceutical therapies, announced ...

FDA approves oral ghrelin agonist for adult GH deficiency diagnosis

The FDA has approved the oral ghrelin agonist macimorelin to be used in the diagnosis of patients with adult growth hormone deficiency, according to a press release from Aeterna Zentaris.Macimorelin (...

Investors continue to like Aeterna’s Macrilen deal

Canada-based Aeterna Zentaris’ share price has continued to climb since the announcement of a licensing…

Strongbridge gets US and Canadian rights to AEterna's Macrilen

AEterna Zentaris Inc. licensed rare disease-focused Strongbridge Biopharma PLC rights to develop, manufacture, register, and commercialize Macrilen (macimorelin) in the US and Canada.

AEterna Zentaris Investment: A Risk Analysis

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [4 Associated Companies listed on BioPortfolio]


Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women’s health. We are eng...

AEterna Zentaris

Committed to cure by discovering and developing innovative drugs for the treatment of patients suffering from some forms of cancer, endocrinian disorders and infectious diseases, this is our mission. ...

Æterna Zentaris Inc

The Æterna Zentaris group is comprised of healthcare-oriented companies evolving predominantly in the biopharmaceutical as well as personal care industries. Its success depends upon scientific and cl...

AEterna Laboratories Incorporated

Æterna Laboratories Inc. is a biopharmaceutical company focused on the treatment of cancer. The company’s lead product, Neovastat®, is the focus of a number of clinical trials including pivotal tr...

More Information about "AETERNA ZENTARIS INC." on BioPortfolio

We have published hundreds of AETERNA ZENTARIS INC. news stories on BioPortfolio along with dozens of AETERNA ZENTARIS INC. Clinical Trials and PubMed Articles about AETERNA ZENTARIS INC. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AETERNA ZENTARIS INC. Companies in our database. You can also find out about relevant AETERNA ZENTARIS INC. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record